Asia-Pacific Journal of Medicine

| Peer-Reviewed |

The Research Status of Class II Histone Deace-tylases Physiological Function

Received: 29 November 2019    Accepted: 19 February 2020    Published: 6 March 2020
Views:       Downloads:

Share This Article

Abstract

Histone deace-tylases (HDACs) are proteases, The main function of HDACs are to modify the structure of chromosomes and regulate gene expression in organisms. HDACs can catalyze the deacetylation of histones, regulate histone acetylation process and deacetylation process in the nucleus, and maintain its dynamic balance state, which is closely related to the occurrence of cell apoptosis, oxidative stress and with it inflammatory response, metabolic disorders, senescence, tumor and other processes in living things. There are many members of the HDACs family, as many as 18 of which have been discovered so far, was divided into classesI, classesIIa, classesIIb, classesIII and classesIV, The structure, function, subcellular localization and expression patterns of each enzyme are not the same. In recent years, the physiological function of classII HDACs is more widespread attention by researchers, In this paper, we will review the physiological function of classII HDACs in the regulation of bone formation, skeletal muscle regulation, cardiovascular growth and formation, endothelial cells, cytoskeletal dynamics and so on, It also gives a brief description of possible research directions of HDACs, so that it can be widely used in clinical treatment and play a positive therapeutic role.

Published in Asia-Pacific Journal of Medicine (Volume 3, Issue 1, March 2020)
Page(s) 1-4
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Histone Deace-tylases, HDAC, HAT, Dach2, RUNX2

References
[1] 曾考娟, 关日辉, 赖天文, 等. HDAC6在呼吸系统疾病中的作用研究进展[J]. 海南医学, 2019, 30(07):99-913.
[2] LEE SC, MIN HY, JUNG HJ, et al. Essential role of insulin-like growth factor 2 in resistance to resistance to histone deacetylase inhibitors [J]. Oncogene, 2016, 35 (42): 5515-5526.
[3] Young PE, Youngwoo W, Jin KS, et al. Anticancer effects of a new SIRTinhibitor, MHY2256, againsthuman breast cancer mcf-7 cells via regulation of MDM2-p53 binding[J]. International Journal of Biological Sciences, 2016, 12 (12): 1555-1567.
[4] Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy [J]. Nature Reviews. Genetics, 2009, 10 (1): 32-42.
[5] Vega RB, Harrison BC, Meadows Eric, et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5 [J]. Mol Cell Biol, 2004, 24 (19): 8374-8385.
[6] McKinsey TA, Zhang CL, Lu J, et al. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation [J]. Nature, 2000, 408 (6808): 106-111.
[7] Lu J, McKinsey TA, Nicol RL, et al. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases [J]. Proceedings of the National Academy of Sciences, 2000, 97 (8): 4070-4075.
[8] Passier R, Zeng H, Frey N, et al. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo [J]. Journal of Clinical Investigation, 2000, 105 (10): 1395-1406.
[9] Lu J, McKinsey TA, Zhang CL, et al. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class Ⅱ histone deacetylases [J]. Molecular Cell, 2000, 6 (2): 233-244.
[10] Youn HD, Grozinger CM, Liu JO. Calcium Regulates Transcriptional Repression of Myocyte Enhancer Factor 2 by Histone Deacetylase 4 [J]. Journal of Biological Chemistry, 2000, 275 (29): 22563-22567.
[11] Wang AH, Bertos NR, Vezmar M, et al. HDAC4, a Human Histone Deacetylase Related to Yeast HDA1, Is a Transcriptional Corepressor [J]. Molecular and Cellular Biology, 1999, 19 (11): 7816-7827.
[12] Miska EA, Karlsson C, Langley E, et al. HDAC4 deacetylase associates with and represses the MEF2 transcription factor [J]. The EMBO Journal, 1999, 18 (18): 5099-5107.
[13] Sparrow DB, Miska EA, Langley E, et al. MEF-2 function is modified by a novel co-repressor, MITR [J]. The EMBO Journal, 1999, 18 (18): 5085-5098.
[14] Fischle W, Dequiedt F, Hendzel MJ, et al. Enzymatic activity associated with class Ⅱ HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR [J]. Molecular Cell, 2002, 9 (1): 45-57.
[15] Zhang CL, McKinsey TA, Lu JR, et al. Association of COOH-terminal-binding protein (CtBP) and MEF2-interacting transcription repressor (MITR) contributes to transcriptional repression of the MEF2 transcription factor [J]. J Biol Chem, 2001, 276 (1): 35-39.
[16] Zhang CL, McKinsey TA, Olson EN. Association of class Ⅱ histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation [J]. Mol Cell Biol, 2002, 22 (20): 7302-7312.
[17] Dressel U, Bailey PJ, Wang SC, et al. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation [J]. J Biol Chem, 2001, 276 (20): 17007-17013.
[18] Bassel-Duby R, Olson EN. Signaling pathways in skeletal muscle remodeling [J]. Annu Rev Biochem, 2006, 75 (1): 19-37.
[19] Potthoff MJ, Wu H, Arnold MA, et al. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers [J]. J Clin Invest, 2007, 117 (9): 2459-2467.
[20] Haberland M, Arnold MA, McAnally J, et al. Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation [J]. Mol Cell Biol, 2007, 27 (2): 518-525.
[21] Macpherson Peter C D, Farshi Pershang, Goldman Daniel. Dach2-Hdac9 signaling regulates reinnervation of muscle endplates [J]. Development (Cambridge, England), 2015, 142 (23): 4038-48.
[22] Méjat, Alexandre, Ramond F, Bassel-Duby R, et al. Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression [J]. Nature Neuroscience, 2005, 8 (3): 313-321.
[23] Vega RB, Matsuda K, Oh J, et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis [J]. Cell, 2004, 119 (4): 555-566.
[24] 梁大伟, 卫小春, 魏垒. 组蛋白去乙酰化酶4在软骨与骨发育中的调控机制[J]. 中华关节外科杂志(电子版), 2015, 9(3):394-399.
[25] Chang S, Mckinsey TA, Zhang CL, et al. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development [J]. Mol Cell Biol, 2004, 24 (19): 8467-8476.
[26] Song K, Backs J, McAnally J, et al. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases [J]. Cell, 2006, 125 (3): 453-466.
[27] Chang S, Young BD, Li S, et al. Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10 [J]. Cell, 2006, 126 (2): 321-334.
[28] Lindsey ML, Mann DL, Entman ML, et al. Extracellular matrix remodeling following myocardial injury [J]. Ann Med, 2003, 35 (5): 316-326.
[29] Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer[J]. Oncogene, 2002, 21(14):2245-2252.
[30] Zhang Y, Kwon S, Yamaguchi T, et al. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally [J]. Mol Cell Biol, 2008, 28 (5): 1688-1701.
[31] Fiona R. Kolbinger, Emily Koeneke, Johannes Ridinger, et al. The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines[J]. Archives of Toxicology, 2018, 92(8): 2649-2664.
[32] Ridinger Johannes, Koeneke Emily, Kolbinger Fiona R, et al. Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance [J]. Scientific reports, 2018, 8 (1): 10039.
[33] Tang X, Gao JS, Guan YJ, et al. Acetylation-dependent signal transduction for type I interferon receptor [J]. Cell, 2007, 131 (1): 93-105.
[34] Zhang X, Yuan Z, Zhang Y, et al. HDAC6 modulates cell motility by altering the acetylation level of cortactin [J]. Mol Cell, 2007, 27 (2): 197-213.
[35] Kovacs JJ, Murphy PJ, Gaillard S, et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor [J]. Mol Cell, 2005, 18 (5): 601-607.
[36] Matsuyama A, Shimazu T, Sumida Y, et al. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation [J]. EMBO J, 2002, 21 (24): 6820-6831.
[37] Hubbert C, Guardiola A, Shao R, et al. HDAC6 is a microtubule-associated deacetylase [J]. Nature, 2002, 417 (6887): 455-458.
[38] Yudibeth Sixto-López, Martiniano Bello, José Correa-Basurto. Structural and energetic basis for the inhibitory selectivity of both catalytic domains of dimeric HDAC6 [J]. Journal of Biomolecular Structure and Dynamics, 2019, 37 (18): 4701-4720.
Cite This Article
  • APA Style

    Jianyu Wang, Songpo Yao, Xingzhou Li, Xiaoxia Xu, Ruidi Zhang, et al. (2020). The Research Status of Class II Histone Deace-tylases Physiological Function. Asia-Pacific Journal of Medicine, 3(1), 1-4.

    Copy | Download

    ACS Style

    Jianyu Wang; Songpo Yao; Xingzhou Li; Xiaoxia Xu; Ruidi Zhang, et al. The Research Status of Class II Histone Deace-tylases Physiological Function. Asia-Pac. J. Med. 2020, 3(1), 1-4.

    Copy | Download

    AMA Style

    Jianyu Wang, Songpo Yao, Xingzhou Li, Xiaoxia Xu, Ruidi Zhang, et al. The Research Status of Class II Histone Deace-tylases Physiological Function. Asia-Pac J Med. 2020;3(1):1-4.

    Copy | Download

  • @article{10045225,
      author = {Jianyu Wang and Songpo Yao and Xingzhou Li and Xiaoxia Xu and Ruidi Zhang and Ye Lu and Liangchen Liu and Baosheng Guan and Xianglin Yin},
      title = {The Research Status of Class II Histone Deace-tylases Physiological Function},
      journal = {Asia-Pacific Journal of Medicine},
      volume = {3},
      number = {1},
      pages = {1-4},
      url = {https://www.sciencepublishinggroup.com/article/10045225},
      abstract = {Histone deace-tylases (HDACs) are proteases, The main function of HDACs are to modify the structure of chromosomes and regulate gene expression in organisms. HDACs can catalyze the deacetylation of histones, regulate histone acetylation process and deacetylation process in the nucleus, and maintain its dynamic balance state, which is closely related to the occurrence of cell apoptosis, oxidative stress and with it inflammatory response, metabolic disorders, senescence, tumor and other processes in living things. There are many members of the HDACs family, as many as 18 of which have been discovered so far, was divided into classesI, classesIIa, classesIIb, classesIII and classesIV, The structure, function, subcellular localization and expression patterns of each enzyme are not the same. In recent years, the physiological function of classII HDACs is more widespread attention by researchers, In this paper, we will review the physiological function of classII HDACs in the regulation of bone formation, skeletal muscle regulation, cardiovascular growth and formation, endothelial cells, cytoskeletal dynamics and so on, It also gives a brief description of possible research directions of HDACs, so that it can be widely used in clinical treatment and play a positive therapeutic role.},
     year = {2020}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - The Research Status of Class II Histone Deace-tylases Physiological Function
    AU  - Jianyu Wang
    AU  - Songpo Yao
    AU  - Xingzhou Li
    AU  - Xiaoxia Xu
    AU  - Ruidi Zhang
    AU  - Ye Lu
    AU  - Liangchen Liu
    AU  - Baosheng Guan
    AU  - Xianglin Yin
    Y1  - 2020/03/06
    PY  - 2020
    T2  - Asia-Pacific Journal of Medicine
    JF  - Asia-Pacific Journal of Medicine
    JO  - Asia-Pacific Journal of Medicine
    SP  - 1
    EP  - 4
    PB  - Science Publishing Group
    UR  - http://www.sciencepg.com/article/10045225
    AB  - Histone deace-tylases (HDACs) are proteases, The main function of HDACs are to modify the structure of chromosomes and regulate gene expression in organisms. HDACs can catalyze the deacetylation of histones, regulate histone acetylation process and deacetylation process in the nucleus, and maintain its dynamic balance state, which is closely related to the occurrence of cell apoptosis, oxidative stress and with it inflammatory response, metabolic disorders, senescence, tumor and other processes in living things. There are many members of the HDACs family, as many as 18 of which have been discovered so far, was divided into classesI, classesIIa, classesIIb, classesIII and classesIV, The structure, function, subcellular localization and expression patterns of each enzyme are not the same. In recent years, the physiological function of classII HDACs is more widespread attention by researchers, In this paper, we will review the physiological function of classII HDACs in the regulation of bone formation, skeletal muscle regulation, cardiovascular growth and formation, endothelial cells, cytoskeletal dynamics and so on, It also gives a brief description of possible research directions of HDACs, so that it can be widely used in clinical treatment and play a positive therapeutic role.
    VL  - 3
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • School of Public Health, Jiamusi University, Jiamusi, China

  • School of Public Health, Jiamusi University, Jiamusi, China; Heilongjiang Key Laboratory of Gout Research, Jiamusi, China

  • School of Public Health, Jiamusi University, Jiamusi, China; Heilongjiang Key Laboratory of Gout Research, Jiamusi, China

  • School of Stomatology, Jiamusi University, Jiamusi, China

  • School of Public Health, Jiamusi University, Jiamusi, China

  • School of Public Health, Jiamusi University, Jiamusi, China

  • School of Public Health, Jiamusi University, Jiamusi, China

  • School of Public Health, Jiamusi University, Jiamusi, China; Heilongjiang Key Laboratory of Gout Research, Jiamusi, China

  • School of Public Health, Jiamusi University, Jiamusi, China; Heilongjiang Key Laboratory of Gout Research, Jiamusi, China

  • Sections